Other Event

Other Event

Other Adverse Events are non-serious adverse events that exceed a specific frequency threshold (typically 5% within any study arm). These events are reported to provide comprehensive safety information about all noteworthy adverse occurrences during clinical trials. Each other event is categorized by term, organ system, assessment type, and source vocabulary for standardized reporting.

Other Event path is as follows:

Study -> Results Section -> Adverse Events Module -> Other Event

Study -> Results Section -> Adverse Events Module -> Other Event -> Other Event Stats

Other Event


Ignite Creation Date: 2025-12-25 @ 1:43 AM
Ignite Modification Date: 2025-12-26 @ 12:01 AM
NCT ID: NCT04542694
Term: Increased alanine aminotransferase activity
Organ System: Hepatobiliary disorders
Assessment Type: SYSTEMATIC_ASSESSMENT
Source Vocabulary: MedDRA
Notes: According to investigators, the causal relationship with the study drug was estimated as "unrelated" in 22.2%
Study: NCT04542694
Study Brief: Study of Favipiravir Compared to Standard of Care in Hospitalized Patients With COVID-19
Other Event Stats (If Any):

Other Event Stats

Group ID # Events # Affected # At Risk View
EG001 None 19 100 View
EG000 None 18 100 View